Ronald M. Schwartz, MD, of the Neurological Research Center at Hattiesburg Clinic, MS gives an interview about the DaTscan test, an imaging agent that was approved by the FDA this year. The DaTscan is a nuclear medicine test that enables doctors to differentiate between Parkinsonian syndromes and essential tremors.
Please login or register first to view this content.